The report 'Elastomeric Infusion Pumps Market by Type (Continuous Rate and Variable Rate), Application (Chemotherapy, Pain ...

Requirements vary by lender, but typically, business owners need to provide two to three years of business returns, along ...

With the Fed likely to be lowering rates until next summer, now is the time to load up on five of our favorite blue-chip ...

Steady Recurring Revenue* Growth and Adjusted EBITDA Margin* Expansion TORONTO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Altus Group Limited (ʺAltus ...

TELUS faces headwinds from sector competition, high leverage, and a challenging dividend payout ratio. Click here to read an ...

Late Thursday, New York-based Warburg announced an agreement to buy ECN, run by entrepreneur and chief executive officer ...

U.S. hospitals face thin margins. Expiring ACA tax credits could further strain finances, impacting medical device & tech ...

Baxter updated its full-year 2025 guidance, expecting total sales growth of 4% to 5% on a reported basis, incorporating approximately $320 million of anticipated MSA revenues from Vantive and a 50 ...

Scott Galovan noted a "decline of over 20%" in hyaluronic acid injections and intravenous infusion product lines in fiscal Q3 ...

The intracoronary fibrinolysis infusion joins a host of other failed treatments to improve microvascular obstruction after STEMI.

The sports data and betting technology landscape has undergone a seismic transformation over the past two decades, and at the ...

Reports record revenue of $21.2 million for the third quarter of 2025, an increase of $2.9 million, or 16%, compared to the same period in ...